Pharmacotherapy of postpartum depression: an update
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Postpartum depression (PPD) is a common and serious illness that affects up to 14% of women in the first month after childbirth. We present an update on the pharmacologic treatment of PPD, although there continues to be a lack of large, randomized controlled trials (RCTs). AREAS COVERED: A review of the literature on the use of antidepressants, hormonal supplements and omega-3 fatty acids for the prevention and the treatment of PPD published since the original review in 2009 and the authors' opinion on the current status of the pharmacological treatment of PPD are covered. An electronic search was performed by using PubMed, Medline and PsychINFO. Inclusion criteria were: i) empirical articles in peer-reviewed English-language journals; ii) well-validated measures of depression; and iii) a uniform scoring system for depression among the sample. EXPERT OPINION: Since the last Expert Opinion review, four antidepressant treatment studies and one prevention study of PPD have been published. Six RCTs evaluating the use of omega-3 fatty acids (four for prevention and two for treatment) have been published. There continues to be lack of data regarding the pharmacotherapy of PPD. However, serotonin reuptake inhibitors should be considered first-line for women with PPD after it has been determined that the proper diagnosis is not bipolar disorder. It is important to individualize treatment for women with PPD and consider the risks and benefits of treatment while breastfeeding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“However, it is essential to augment a patient’s qualitative report with a standard measure of response and remission to better monitor her progress over time [87].”
Postpartum depression: current status and future directions
O'Hara, M. W., & McCabe, J. E. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185612 · Cited by 1,750 · cited 3×
“1 Antidepressants and prevention of PPD PPD prevention programs fall into one of three main categories: universal (all pregnant women), selective (women with specific risk factors) and indicated (symptomatic) [4].”
InfluentialHirschfeld, R. M. A., Williams, J. B. W., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck, P. E., Lewis, L., McElroy, S. L., Post, R. M., Rapport, D. J., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1873 · Cited by 1,525
Wisner, K. L., Sit, D. K. Y., McShea, M. C., Rizzo, D. M., Zoretich, R. A., Hughes, C. L., Eng, H. F., Luther, J. F., Wisniewski, S. R., Costantino, M. L., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.87 · Cited by 1,091 · cited 3×
“More recently, a positive EPDS screen of 10 or greater was associated with an Axis I disorder (most commonly unipolar depression) in 98% of women screened [10].”
Self-citationEffects of gonadal steroids in women with a history of postpartum depression
Bloch, M., Schmidt, P. J., Danaceau, M., Murphy, J., Nieman, L., & Rubinow, D. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.924 · Cited by 950
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 1×
“Based on the general depression treatment guidelines, women should be continued for at least 9 -- 12 months once they have achieved remission of symptoms [84,85].”
Wisner, K. L., Parry, B. L., & Piontek, C. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011542 · Cited by 666 · cited 1×
“Without treatment, women with a history of PPD have a 50% chance of relapse [15,15,53,82].”
Self-citationMakrides, M., Gibson, R. A., McPhee, A. J., Yelland, L., Quinlivan, J., Ryan, P., & DOMInO Investigative Team, A. T. (2010) · JAMA · doi:10.1001/jama.2010.1507 · Cited by 559
Risks and predictors of readmission for a mental disorder during the postpartum period
Munk-Olsen, T., Laursen, T. M., Mendelson, T., Pedersen, C. B., Mors, O., & Mortensen, P. B. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.528 · Cited by 299 · cited 2×
“However, the continued restriction to 4 weeks postpartum is not in line with recent data suggesting that risk increases through [13,79] 3 -- 5 months postpartum.”
Does maternal postpartum depressive symptomatology influence infant feeding outcomes?
Dennis, C., & McQueen, K. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00184.x · Cited by 257
Cited by
Meltzer-Brody, S., Colquhoun, H., Riesenberg, R., Epperson, C. N., Deligiannidis, K. M., Rubinow, D. R., Li, H., Sankoh, A. J., Clemson, C., Schacterle, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31551-4 · Cited by 795
Self-citationThe Neurobiology of Postpartum Anxiety and Depression
Pawluski, J. L., Lonstein, J. S., & Fleming, A. S. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2016.11.009 · Cited by 325
Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression
Kanes, S. J., Colquhoun, H., Doherty, J., Raines, S., Hoffmann, E., Rubinow, D. R., & Meltzer-Brody, S. (2017) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2576 · Cited by 151
“Among pharmacological approaches, SSRIs tend to be preferred despite varying response rates (Austin et al., 2013; Kim et al., 2014; Misri et al., 2016), suggesting a need for more targeted PPD therapies.”
BackgroundLüscher, B., & Möhler, H. (2019) · F1000Research · doi:10.12688/f1000research.18758.1 · Cited by 105
Metadata
- Authors
- Kim, D. R., Epperson, C. N., Weiss, A. R., & Wisner, K. L.
- Venue
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa Healthcare
- Published
- 2014-04-29
- Volume
- 15
- Issue
- 9
- Pages
- 1223-1234
- ISSN
- 1465-6566 (ISSN-L)
- 1744-7666
- OpenAlex
- W2065778846
- Cited by
- 73
- References
- 27
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacotherapy of postpartum depression: an update. https://app.cochat.ai/papers/10.1517/14656566.2014.911842
- The paper
- Kim, D. R., Epperson, C. N., Weiss, A. R., & Wisner, K. L. (2014). Pharmacotherapy of postpartum depression: an update. Expert Opinion on Pharmacotherapy. https://doi.org/10.1517/14656566.2014.911842
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.